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Abstract
Background: Neph3 (filtrin) is expressed in the glomerular podocytes where it localizes at the
specialized cell adhesion structures of the foot processes called slit diaphragms which form the
outermost layer of the glomerular filtration barrier. Neph3 protein shows homology and structural
similarity to Neph1, Neph2 and nephrin, which all are crucial for maintaining the normal glomerular
ultrafiltration function. The exact function of Neph3 in the kidney is not known but we have
previously shown that the level of Neph3 mRNA is decreased in proteinuric diseases. This suggests
that Neph3 may play a role in the pathogenesis of kidney damage, and emphasizes the need to
analyze the regulatory mechanisms of Neph3 gene. In this study we investigated the transcriptional
regulation of Neph3 gene by identifying transcription factors that control Neph3 expression.
Results: We cloned and characterized approximately 5 kb fragment upstream of the Neph3 gene.
Neph3 proximal promoter near the transcription start site was found to be devoid of TATA and
CAAT boxes, but to contain a highly GC-rich area. Using promoter reporter gene constructs, we
localized the main activating regulatory region of Neph3 gene in its proximal promoter region from
-105 to -57. Within this region, putative transcription factor binding sites for NF-κB and Sp1 were
found by computational analysis. Mutational screening indicated that NF-κB and Sp1 response
elements are essential for the basal transcriptional activity of the Neph3 promoter. Co-transfection
studies further showed that NF-κB and Sp1 regulate Neph3 promoter activity. In addition,
overexpression of NF-κB increased endogenous Neph3 gene expression. Chromatin
immunoprecipitation assay using cultured human podocytes demonstrated that both NF-κB and
Sp1 interact with the Neph3 promoter.
Conclusion: Our results show that NF-κB and Sp1 are key regulators of Neph3 expression at the
basal level in podocytes, therefore providing new insight into the molecular mechanisms that
contribute to the expression of Neph3 gene.
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The glomerular filtration barrier consists of a fenestrated
endothelium, a glomerular basement membrane and
glomerular epithelial cells, podocytes. Podocytes sur-
round the basement membrane of glomerular capillaries
from the outside and present foot processes that are
linked to each other with unique cell junction structures,
the slit diaphragms (SD). According to the present view,
SDs form the final barrier preventing leakage of plasma
proteins from circulation to urine [1].
Neph3, also known as filtrin, is a member of the Neph
(nephrin-like proteins) family and shows sequence
homology and structural similarity to two other Neph
proteins, Neph1 and Neph2, and to nephrin [2-5]. All
these are transmembrane proteins that belong to the
immunoglobulin superfamily [3-5]. In podocytes, Neph3,
like other Neph family proteins and nephrin, localizes at
the slit diaphragm [2,6-10]. Nephrin appears to be a key
component of the SD and genetic nephrin deficiency
results in the absence of SD and massive proteinuria in
humans and mice [11-13]. Similarly, in Neph1-deficient
mice, the podocyte foot processes are effaced and the mice
exhibit severe proteinuria [14]. The function of Neph3 in
the kidney is less well known but sequence homology and
similar location with other Neph proteins and nephrin
suggests that it has shared functions as a structural and sig-
naling component of filtration barrier. In addition, the
expression of Neph3 is down-regulated, similarly to
nephrin mRNA, in human proteinuric diseases proposing
it to have a role in maintaining normal SD structure and
function [7]. However, very little is known about the
mechanisms that regulate human Neph genes and the
mechanisms behind the transcriptional regulation of
Neph3 gene have not been elucidated at all.
To better understand the role of Neph3 in the SD under
normal and pathophysiological conditions, we investi-
gated the transcriptional regulation of Neph3 and identi-
fied the key regulatory regions in the Neph3 5' promoter.
Further, we show that transcription factors nuclear factor-
kappa B (NF-κB) and specificity protein 1 (Sp1) bind to
the promoter and are essential in controlling Neph3
expression.
Results
Features of the upstream region of the human Neph3 gene
The human Neph3 gene (official HUGO gene name
KIRREL2) consists of fifteen exons. It locates on chromo-
some 19q13.12, adjacent to nephrin, and encodes a 107
kDa protein. There are at least 5 different splicing variants
of Neph3 that appear to have distinct tissue specificity
[4,5]. All known variants have the same transcription start
site. Mouse and rat have syntenic Neph3 gene regions in
their chromosome locations 7qB1 and 1q21, respectively.
We examined approximately 5000 bp 5' flanking region
upstream from the Neph3 transcription start site [Gen-
Bank: AC002133]. Neph3 proximal promoter near the
transcription start site was noticed to lack a typical TATA
and CAAT boxes, but instead found to contain a highly
GC-rich area. A CpG island (percentage of C or G: 63.1%
and ratio of observed to expected CpG: 0.70) was located
around the proximal promoter from -765 to +292 using
the Blat tool http://genome.ucsc.edu/. CpG islands are
generally found in the promoter regions of housekeeping
genes and the cytosines within these regions are typically
kept unmethylated to allow the expression of the corre-
lated genes [15]. The CpG island also includes several GC
boxes, detected by MatInspector software (Genomatix),
that are important for the expression of many different
ubiquitous as well as tissue-specific cellular and viral
genes [16]. Two primate specific Alu-repetition sequences
were identified in the region -3021 to -2795 and from -
2544 to -2317 bp upstream from the transcription start
site using Genomic repeats tool in Genomatix.
Location of the active promoter regions
To locate the minimal sequence responsible for the basal
transcription of the human Neph3 gene, a series of luci-
ferase reporter plasmids containing various lengths of the
Neph3 5'-flanking region were constructed and tran-
siently transfected into human embryonic kidney cells
(A293 cell line) that express Neph3 mRNA endogenously
(Figure 1). As shown in Figure 2, already the Neph3 5' -57
promoter region activated the reporter gene to some
extent, but the highest luciferase activity was produced by
the Neph3 5' -105 construct. This indicates that the essen-
Neph3 mRNA is expressed endogenously in human A293 embryonic kidney cell lin  and in differentiated human podo-cytesFigure 1
Neph3 mRNA is expressed endogenously in human 
A293 embryonic kidney cell line and in differentiated 
human podocytes. To determine the endogenous expres-
sion of Neph3 mRNA in A293 cells and differentiated human 
podocytes, total RNA was extracted, reverse transcribed, 
and expression of Neph3 mRNA was analyzed by conven-
tional PCR using gene-specific primers. The amplification 
products were visualized on a 1.5% agarose gel. In the 
reverse transcriptase positive (RT+) samples, the amplifica-
tion products were detectable and their identity was con-
firmed by sequencing. In the RT- samples and H2O sample, 
which represents a no-template control, no amplification 
products were detectable confirming the RNA origin of the 
PCR signals.Page 2 of 12
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level transcription are located within the region of -105 to
-57. The constructs Neph3 5' -2260, Neph3 5' -1072,
Neph3 5' -536, Neph3 5' -366, Neph3 5' -162 showed
approximately the same luciferase activity. Neph3 5' -
3877 construct and Neph3 5' -162 construct had signifi-
cantly lower luciferase activities compared to luciferase
activities of Neph3 5' -2260 construct and Neph3 5' -105
construct, respectively, suggesting the presence of repress-
ing transcription factor binding elements in the regions -
3877 to -2260 and -162 to -105. Both identified Alu repe-
tition sequences locate in the region from -3021 to -2317
in the Neph3 5' -3877 construct and may also be the rea-
son for the lower activity of this part of the promoter. The
longest construct Neph3 5' -5070 produced higher luci-
ferase activity than Neph3 5' -4543 or Neph3 5' -3877
implying that in addition to proximal promoter region
from -105 to -57, there is possibly also another, weaker
enhancer site in the distal 5' region from -5070 to -3877.
NF-κB and Sp1 response elements are essential for the 
basal transcriptional activity of the Neph3 promoter
Reporter gene analysis indicated that the region of -105 to
-57 in Neph3 promoter contains the essential regulatory
elements. To locate putative binding sites for transcription
factors within this promoter region, we used MatInspector
software. The region was shown to contain putative bind-
ing sites for NF-κB (gcGGGAgtttct, where core binding site
is marked with Caps) at the position -85 to -74 and for
Sp1 (aagagGGCGgagctc) at the position -66 to -52 (Fig-
ures 3A and 3B). Core/matrix similarity values were
1.000/0.886 and 1.000/0.930 for the NF-κB and Sp1
binding sites, respectively. To investigate the functionality
of these sites, NF-κB and Sp1 elements were mutated in
the Neph3 5' -105 construct and the constructs were trans-
fected into A293 cells. As shown in Figure 3C, mutation of
NF-κB element decreased transcriptional activity by 39%
and mutation of Sp1 element by even 80% indicating that
both elements are functional and essential for the basal
level transcription of Neph3. Double mutation of both
elements decreased transcriptional activity of Neph3 5' -
105 region to the same level as Sp1 binding site mutation
alone.
Overexpression of NF-κB and Sp1 activate Neph3 
promoter
Next we studied if NF-κB and Sp1 are able to activate
Neph3 promoter. NF-κB is a transcription factor family
consisting of different subunits which function as homo-
or heterodimers. Heterodimer consisting of p50 and p65
subunits and p65 homodimer are the well known dimers
participating in gene transactivation [17], and both p50
and p65 have been shown to be expressed in podocytes
[18,19]. Therefore, we studied the effect of p50 and p65
overexpression on Neph3 promoter activity. Neph3 5' -
105 construct was co-transfected together with NF-κB p50
Transcriptional activity of the 5'-flanking regions of the human Neph3 gene in A293 cellsFigure 2
Transcriptional activity of the 5'-flanking regions of the human Neph3 gene in A293 cells. A series of luciferase 
(LUC) reporter plasmids containing various lengths of the Neph3 5'-flanking region was constructed. Negative numbers indi-
cate the 5' end of the promoter fragment relative to the major transcription start site at +1. The reporter plasmids were trans-
fected into A293 cells and luciferase activities were measured 24 h after transfection. The activities produced by the studied 
constructs were normalized against co-transfected control plasmid (phRL-TK) activities. The values represent means +S.D. of 
a representative experiment performed in triplicate. Each experiment was carried out three times with similar results. To con-
firm the results, statistical difference for the key observation (Neph3 5' -105 versus Neph3 5' -162) was calculated in three indi-
vidual experiments using independent samples t-test. *** p < 0.001.Page 3 of 12
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Figure 4, p65 over-expression resulted in activation of
Neph3 promoter with 3.3-fold induction compared to
control. Over-expression of p50 subunit had no effect on
Neph3 promoter activity. Simultaneous overexpression of
p50 and p65 subunits led to no further activation of
Neph3 promoter, but instead, to lower levels of activity
than with p65 subunit alone. Furthermore, luciferase
activity of Neph3 5' -105 construct containing mutated
NF-κB binding site was not altered. These results sug-
gested that NF-κB (subunit p65) is able to stimulate
Neph3 transcription through NF-κB binding site in the
position of -85 to -74.
Sp1 over-expression studies were carried out in Drosophila
Schneider 2 (S2) cells. This is an established in vitro model
to study the role of Sp1, since these cells lack endogenous
Sp1, while all mammalian cell lines (including A293
cells) have high endogenous level of Sp1 and therefore are
not suitable for Sp1 over-expression studies [20]. Neph3
5' -105 construct was co-transfected together with Sp1
expression vector, and as shown in Figure 5, Sp1 overex-
pression resulted in activation of Neph3 promoter with
1.6-fold induction compared to control. In contrast,
mutation of Sp1 binding site abolished activation. These
results indicated that Sp1 activates Neph3 transcription
through Sp1 binding site in the position of -66 to -52.
NF-κB and Sp1 response elements are essential for the basal level transcription of Neph3 in A293 cellsFigure 3
NF-κB and Sp1 response elements are essential for the basal level transcription of Neph3 in A293 cells. (A) A 
schematic representation of the Sp1 and NF-κB binding sites in the Neph3 promoter. (B) Nucleotide sequence of the human 
Neph3 promoter from -105 bp to TSS. The putative binding sites for NF-κB and Sp1 are boxed and core binding site is marked 
with Caps. The transcription start site is marked with +1. (C) Mutational analysis of the Sp1 and NF-κB binding sites in the 
Neph3 promoter. The Neph3 5' -Luc plasmids with mutated Sp1 and NF-κB binding sites were transfected into A293 cells and 
luciferase (LUC) activities were measured 24 h after transfection. The activities produced by the studied constructs were nor-
malized against co-transfected control plasmid (phRL-TK) activities. The luciferase activities produced by the mutant con-
structs were compared with the activity produced by the unmutated construct. The values are presented as percentages of 
unmutated construct, which was set at 100% The values represent means +S.D. from three independent experiments per-
formed in triplicate. Statistical difference of the promoter activity, using independent samples t-test, is shown against unmu-
tated construct transfection. *** p < 0.001.Page 4 of 12
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We also examined whether NF-κB has an effect on the
expression of endogenous Neph3 mRNA. NF-κB p50 and
p65 subunits were transiently transfected into A293 cells
and after 48 h RNA was extracted and Neph3 mRNA was
quantified by quantitative PCR. As shown in Figure 6,
simultaneous over-expression of NF-κB p50 and p65 sub-
units increased Neph3 mRNA more than 4-fold compared
to control. A lesser, although significant, increase of
Neph3 mRNA was also seen when p65 subunit was trans-
fected alone. In contrast, Neph3 mRNA level was not sig-
nificantly different between p50 transfected and control
cells. These findings demonstrate that forced expression of
NF-κB p50 and p65 drive Neph3 gene expression in A293
cells.
NF-κB and Sp1 bind to the promoter region of Neph3
In order to study the interaction of NF-κB and Sp1 with
Neph3 promoter ex vivo, a chromatin immunoprecipita-
tion assay was carried out. NF-κB p65, p50 and Sp1 anti-
bodies were used to precipitate DNA-protein complexes
from conditionally immortalized human podocyte cell
line that express Neph3 mRNA endogenously (Figure 1).
Immunoprecipitated DNA fragment including NF-κB and
Sp1 binding sites was amplified by real-time PCR. Both
NF-κB subunit p65 and Sp1 were shown to interact with
Neph3 promoter, whereas NF-κB p50 antibody and rabbit
IgG used as a negative control did not precipitate the pro-
moter fragment (Figure 7). Due to different affinities of
the used antibodies, the binding properties of the studied
transcription factors cannot be compared.
Discussion
Neph3 is a member of the nephrin-like protein family and
localizes at the slit diaphragms of podocyte foot processes
which form the outermost layer of the kidney filtration
Overexpression of NF-κB activates Neph3 promoter in A293 cellsFigure 4
Overexpression of NF-κB activates Neph3 promoter 
in A293 cells. The expression vector for p50 or/and p65 
NF-κB (NF-κB family members p50 and p65) was co-trans-
fected with the Neph3 5' -105-Luc reporter plasmid or with 
reporter plasmid containing a mutated NF-κB binding site 
(Neph3 5' -105/NF-κBmut -Luc) into A293 cells and luci-
ferase activities were measured 24 h after transfection. The 
activities produced by the studied constructs were normal-
ized against co-transfected control plasmid (phRL-TK) activi-
ties. The results are presented as fold induction of the 
control experiment co-transfected with corresponding 
empty vector. The values represent means +S.D. from three 
independent experiments performed in triplicates. Statistical 
difference of the promoter activity, using independent sam-
ples t-test, is shown against the control co-transfection. *** p 
< 0.001.
Overexpression of Sp1 activates Neph3 promoter in Dro-sophila S2 cellsFigure 5
Overexpression of Sp1 activates Neph3 promoter in 
Drosophila S2 cells. The Drosophila expression vector for 
Sp1 was co-transfected with the Neph3 5' -105-Luc reporter 
plasmid or with reporter plasmid containing a mutated Sp1 
binding site (Neph3 5' -105/Sp1mut-Luc) into Drosophila S2 
cells and luciferase activities were measured 48 h after trans-
fection. The activities produced by the studied constructs 
were normalized against protein concentration. The results 
are presented as fold induction of the control experiment 
co-transfected with corresponding empty vector. The values 
represent means +S.D. from three independent experiments 
performed in triplicates. Statistical difference of the pro-
moter activity, using independent samples t-test, is shown 
against the control co-transfection. ** p < 0.01Page 5 of 12
(page number not for citation purposes)
BMC Molecular Biology 2009, 10:83 http://www.biomedcentral.com/1471-2199/10/83barrier. Besides the sequence homology of Neph3 with
nephrin and other nephrin-like molecules, the known
crucial components of the kidney filtration barrier, its
structure, location, and down regulation in proteinuric
diseases suggest that it plays an important role in main-
taining the normal glomerular normal ultrafiltration. The
aim of this study was to gain insight into the transcrip-
tional regulation of Neph3 by identifying transcription
factors that control Neph3 expression. Using reporter
gene constructs, we identified the Neph3 5' promoter
region that is essential for the basal level transcription. By
computational analysis, the putative transcription factor
binding elements for NF-κB and Sp1 in this region were
identified within this region and shown to be functional
by site-directed mutagenesis. Furthermore, over-expres-
sion and chromatin immunoprecipitation studies indi-
cated that NF-κB and Sp1 indeed activate and bind to
Neph3 promoter.
Sp1 is a member of Sp family of transcription factors
which contain a conserved set of Cys2-His2 zinc-fingers
representing a DNA-binding domain. Sp1 is ubiquitously
expressed in mammalian cells. It can bind to and act
through GC boxes to regulate gene expression of many
housekeeping, tissue-specific, viral and inducible genes
[21]. Previously, Sp1 has been shown to play a role in reg-
ulating basal level transcription of two other podocyte
proteins, CD2-associated protein [22] and podocalyxin
[23]. Sp1 is a constitutively active transcription factor
[24], and Sp1 binding motifs are shown to be involved in
the maintenance of the methylation-free status of the CpG
islands [25]. Sp1 response element identified in this study
also locates in the CpG island. Therefore, and similarly to
the regulation of many other TATA-less genes [26], we
propose that Sp1 functions as a key regulator of the
Neph3 gene expression at the basal level.
NF-κB, a β-scaffold transcription factor family, plays an
essential role in the regulation of many genes involved in
immune and inflammatory responses, and in cell prolifer-
ation, differentiation and apoptosis [27]. The subcellular
location of NF-κB is controlled by interactions with inhib-
itory proteins of the IκB family which in response to a
large variety of stimuli, such as stress and cytokines, are
phosphorylated, ubiquitinated and degraded thereby free-
ing NF-κB to translocate to the nucleus and to bind DNA
at a response element of the consensus sequence 5'-
GGGRNNYYCC-3' (R = A or G, N = any nucleotide, Y = C
or T) [27]. NF-κB transcription factors exist as hetero- or
homodimers and are formed by different subunits called
p50, p52, c-Rel, RelA/p65 and RelB. Heterodimer consist-
ing of p50 and p65 subunits and p65 homodimer are the
well known dimers and the most abundant ones in most
cell types, including podocytes [17-19,27] In our co-trans-
fection experiments NF-κB p65 subunit together with
Neph3 reporter gene construct resulted in a significant
increase in Neph3 promoter activity. Similarly, the overex-
pression of p65 subunit increased endogenous Neph3
mRNA to some extend (p < 0.05). Interestingly, overex-
pression of p50 and p65 subunits together resulted in a
high increase in the Neph3 mRNA level, but the results
from the reporter gene assay did not show further increase
in promoter activation by combination of p50 and p65. In
addition, we could not detect p50 binding to the pro-
moter in the ChIP assay. It might be that in the chromo-
somal context of the endogenous gene the p50 subunit
binds the promoter and activates the Neph3 expression
together with p65 although this is not seen with reporter
gene constructs or fragmented chromosomes used in
ChIP. However, based on these results it is difficult to con-
clude whether it is p65 homodimer or p50/p65 het-
erodimer that activates the transcription of the Neph3.
Most likely, different NF-κB subunits may heterodimerize
Overexpression of NF-κB increases Neph3 mRNA in A293 cellsFigure 6
Overexpression of NF-κB increases Neph3 mRNA in 
A293 cells. A293 cells were transiently transfected with 
NF-κB p50 and p65 expression plasmids. After 48 h, cells 
were harvested and RNA was isolated. After reverse tran-
scription, the Neph3 mRNA were quantified by quantitative 
reverse transcription-PCR and normalized to the GAPDH 
mRNA using the comparative Ct method (ΔΔCt). The values 
represent means and range of three measurements from two 
individual experiments. Data is presented relative to the con-
trol transfection. The difference to the control transfection is 
statistically significant *** p < 0.001 or * p < 0.05 (independ-
ent samples t-test).Page 6 of 12
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ent ways under various (patho)physiological conditions.
We have previously shown that Neph3 mRNA is
decreased in the kidneys of the diabetic nephropathy
patients [7]. In line with this, nephrin mRNA has been
shown to be downregulated in human diabetic nephrop-
athy [28] and in addition, during the development of dia-
betic nephropathy in a rat model, nephrin mRNA is first
transiently increased and later down-regulated [29]. Inter-
estingly, the activation and nuclear translocation of NF-κB
subunits p50 and p65 have been demonstrated in human
diabetic nephropathy [30,31]. This, together with our
results showing that NF-κB regulates Neph3 expression at
the basal level (this study), prompts for further studies
investigating whether NF-κB plays a role in the regulation
of Neph3 (and possibly also other Neph family members
and nephrin) under diabetic conditions.
The studies with renal biopsies from patients with
acquired human glomerular diseases show correlation,
besides in the mRNA expression of Neph3 and nephrin
[7], also in the mRNA expression of nephrin and other
podocyte-expressed genes, including synaptopodin and
α-actinin-4 [32]. This suggests that common regulatory
mechanisms may be activated in proteinuric glomerular
diseases. Neph3 locates on the same chromosome as
nephrin, 19q13.12, where these genes are arranged in a
head-to-head orientation separated by a 5-kb region [5].
The genomic arrangement of Neph3 and nephrin together
with their similar structure and location, in addition to
the correlation in the mRNA expression of various podo-
cyte-expressed genes [7,32] proposes that Neph3 and
other podocyte genes may share key features in their regu-
lation. However, whether NF-κB and Sp1 control the
expression of nephrin or other podocyte genes is yet to be
clarified.
Besides NF-κB and Sp1, additional transcription factors,
both activating and inhibiting, are likely to participate in
the regulation of Neph3. It has been shown that at least
transcription factor Wilms tumor-1, Snail, retinoic acid
receptors and peroxisome proliferator-activated receptors
regulate nephrin [33-38], and could be involved also in
Neph3 regulation. Interestingly, Sp1 has been demon-
strated to interact with NF-κB, and cooperative functional
and physical interactions between Sp1 and NF-κB have
been shown to be required for example, for HIV-1
enhancer activation [39-41]. Our co-trasfection assays
with Sp1 and NF-κB in A293 cells didn't show any activa-
tion of the Neph3 promoter co-operatively between Sp1
and NF-κB (data not shown). However, Sp1 overexpres-
sion studies are not feasible in mammalian cell lines
because of their high endogenous level of Sp1, which may
be near saturating with regard to induction of reporter
gene expression. Regardless, it is possible that NF-κB and
Sp1 function cooperatively in the Neph3 gene regulation
at the endogenous level. In addition to kidney, Neph3 is
also expressed in other tissues including the β-cells of the
pancreas [4,42] and in the developing central nervous sys-
tem in the brain where it is transiently expressed in early
postmitotic neural precursor cells [43]. It is suggested that
in pancreas and in brain Neph3 is involved in maintain-
ing cell-cell contacts [4,43], but the exact function of
Neph3 in these tissues has not yet been elucidated. Differ-
ent splicing variants of Neph3 also appear to have distinct
tissue specificity. Whether NF-κB and Sp1 also regulate
Neph3 expression and the production of its different
splicing variants in non-renal tissues remains to be eluci-
dated.
Conclusion
In conclusion, in this study we show that the main activat-
ing regulatory region of the Neph3 gene locates in its
proximal promoter region between nucleotides -105 and
-57. Further, we show that transcription factors Sp1 and
NF-κB and Sp1 bind to the promoter region of Neph3 in cul-tured human podocy esFigure 7
NF-κB and Sp1 bind to the promoter region of 
Neph3 in cultured human podocytes. In chromatin 
immunoprecipitation assays, NF-κB and Sp1 antibodies (ab) 
were used to precipitate DNA-protein complexes from dif-
ferentiated human podocytes. Real-time PCR was performed 
with a specific primer pair (shown in Table 1) to amplify 
extracted DNA fragments. (A) Representative agarose gel: 
the input lanes confirm the successful PCR, the ab lanes 
detect the precipitated chromatin, rabbit IgG immunoprecip-
itation was used as a negative control and H2O sample repre-
sents a control sample that does not contain chromatin. (B) 
The relative quantity of DNA was counted by comparing the 
sample fluorescence to the fluorescence values measured 
from total chromatin input dilution series. Columns indicate 
the means of two parallel samples. The experiment was 
repeated twice with similar results.Page 7 of 12
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the transcriptional regulation of the Neph3 gene at the
basal level in podocytes, therefore providing new insight
into the molecular mechanisms that contribute to the
expression of Neph3 gene.
Methods
Cloning of a DNA segment between NPHS1 and Neph3 
genes
Human genomic DNA was isolated from blood using
AquaPure Genomic DNA Kit according to the manufac-
turer's protocol (Bio-Rad, Hercules, CA, USA). A 5276-bp
DNA fragment between NPHS1 and Neph3 genes was
amplified by PCR using DyNAzyme™ EXT DNA polymer-
ase (Finnzymes, Espoo, Finland) from this genomic DNA
using Neph3 5' -5070 genomic primer as sense primer
and Neph3 5' +206 genomic primer as antisense primer
(Table 1). The PCR product was subcloned into a pGlow-
TOPO vector (Invitrogen, Carlsbad, CA, USA) and the
presence of the insert was confirmed by restriction diges-
tion and sequence analysis.
Construction of reporter plasmids
Reporter construct Neph3 5' -5070-Luc was produced by
PCR amplification from the TOPO construct using Neph3
5' -5070 as sense primer and Neph3 5' +48 as antisense
primer (Table 1). The PCR fragment was further sub-
cloned into a pGL3-Basic vector (Invitrogen) upstream of
the luciferase reporter gene using MluI and BglII restric-
tion sites. Deletion constructs with variable lengths of the
Neph3 5'-flanking sequence (Figure 2) were generated
similarly by PCR amplification from the Neph3 5' -5070-
Luc construct. Neph3 5' +48 was used as antisense primer,
respective sense primers are shown in Table 1. The con-
struct Neph3 5' -57 was generated by digestion of the
Neph3 5' -536 construct with SacI followed by re-ligation.
The integrity of all the constructs was verified by sequenc-
ing.
Site-directed mutagenesis
Mutation of the Sp1 and NF-κB binding sites was per-
formed by introducing the point mutations into Neph3 5'
-105 plasmid using the QuikChange™site-directed muta-
genesis kit (Stratagene, La Jolla, CA, USA), according to
the manufacturer's instructions. Oligonucleotides with
site-specific mutations are listed in Table 1. The mutations
were confirmed by sequencing. The Sp1 and NF-κB muta-
tions were designed based on the previous works by
Zhang et al. and Ritchie et al. [44,45], respectively.
Cell culture
A293 (human embryonic kidney cells) [46] were grown in
RPMI 1640 medium (Sigma, St Louis, MO, USA) supple-
mented with 10% fetal bovine serum (Sigma), 2 mM
GlutaMAX (Invitrogen), 100 U/ml penicillin and 100 μg/
ml streptomycin (Sigma). Cells were maintained at 37°C
in a 5% CO2 humidified incubator. Drosophila Schneider
2 (S2) cells, a gift from Prof. Jussi Taipale (University of
Helsinki, Finland), were grown in Express Five SFM (Inv-
itrogen) supplemented with 10% fetal bovine serum
(Sigma), 2 mM GlutaMAX (Invitrogen), 100 U/ml penicil-
lin and 100 μg/ml streptomycin (Sigma) at 25°C without
CO2.
Human conditionally immortalized podocyte cell line
has been previously described and characterized in detail
[47]. Briefly, the cell line contains a transgene encoding a
temperature-sensitive mutant of SV-40 T antigen. Addi-
tionally, the cell line has been stably transfected with the
catalytic domain of the human telomerase gene [48].
Cells proliferate at 33°C, where the SV-40 T antigen is
active, but when cells are moved to 37°C, the antigen is
inactivated, cells stop to proliferate and adopt the pheno-
type of differentiated podocytes. Experiments were per-
formed on podocytes thermo-switched to 37°C for 14
days using passage numbers between 5 and 20. Cells were
cultured in RPMI 1640 medium containing L-glutamine
(Sigma), supplemented with 10% fetal bovine serum and
insulin, transferrin and selenite (Sigma).
Transient transfections and luciferase assay
A293 cells were seeded on 24-well plates on preceding day
of transfections. Cells were transiently transfected using
FuGENE6 (Roche, Basel, Switzerland) with 400 ng of the
Neph3 reporter plasmids together with 5 ng of phRL-TK
plasmid (Promega, Madison, WI, USA) as an internal con-
trol to correct the transfection efficiency. pGL3-Basic
(Promega) plasmid was used as a negative control. Cells
were lysed 24 h after transfection and luciferase activities
were measured using the Dual-Luciferase Reporter Assay
System (Promega) according to the manufacturer's proto-
col. The studied luciferase activities were normalized by
luciferase activities produced by co-transfected phRL-TK
control plasmid.
Overexpression of NF-κB and Sp1
NF-κB overexpression studies were performed in A293
cells. In reporter gene assays, cells were transfected and
luciferase activities were measured as above. For co-trans-
fection of the Neph3 promoter plasmid along with p50
or/and p65 NF-κB (NF-κB family members p50 and p65),
50 ng of the expression plasmids pcDNA3.1/p50 and
pcDNA3.1/p65 (kindly provided by Alan Krensky, Stan-
ford University School of Medicine) were used. The corre-
sponding empty vector pcDNA3.1 was used as a control.
The amount of transfected DNA was maintained constant
with empty pcDNA3.1 vector.
To investigate the effects of NF-κB p50 and p65 subunits
on the endogenous Neph3 RNA level, A293 cells werePage 8 of 12
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Lipofectamine™ 2000 (Invitrogen) with 1.5 μg of p50 or/
and p65 NF-κB expression plasmids. RNA was extracted
48 h after transfection.
Sp1 overexpression studies were done in Drosophila S2
cells lacking endogenous Sp1. Cells were seeded on 12-
well plates and on the following day transiently co-trans-
fected using FuGENE6 (Roche) with 500 ng of Neph3 pro-
Table 1: Oligonucleotides used in the study
Name Positiona Sequence 5'-3'
Primers for endogenous Neph3 mRNA detection
Neph3 5' +481-FW endogenous +481 to +499 TTAGGCCCGTGGAGCTAGA
Neph3 5' +702-RV endogenous +702 to +683 CATCTCGGAACCACAGCAAT
Primers for genomic DNA cloning
Neph3 5' -5070-FW genomic -5070 to -5051 ATCGCGGATCCCACAGGTCCCCCTACTGTGA
Neph3 5' +206-RV genomic +206 to +187 CCCAAGGTTCACGAGATTTG
Primers for reporter constructs
Neph3 5' +48-RV +48 to +31 GACAGATCTCTCTGACGCTCTGAAACG
Neph3 5' -5070-FW -5070 to -5053 GACACGCGTCACAGGTCCCCCTACTGT
Neph3 5' -4543-FW -4543 to -4523 GACACGCGTCCTTGTCTCACTACTCACAGC
Neph3 5' -3877-FW -3877 to -3860 GACACGCGTGTGATCCATCTGCCTCAG
Neph3 5' -2260-FW -2260 to -2240 GACACGCGTCTGTTTGAGACTCTCTCGCTC
Neph3 5' -1072-FW -1072 to -1053 GACACGCGTCTGTCACCCTCTTCCAAGTG
Neph3 5' -536-FW -536 to -518 GACACGCGTGACGTGCTGTAGTTTGCAG
Neph3 5' -366-FW -366 to -352 GACACGCGTGGAAACTGGCGAGGC
Neph3 5' -162-FW -162 to -145 GACACGCGTCAGACCCCAATTGAGCTG
Neph3 5' -105-FW -105 to -89 GACACGCGTCATTCATCCGCGTCTCA
Primers for site-directed mutagenesis b
Neph3 5'-118/NF-κB mutation -96 to -62 GCGTCTCAGCCGCTTAAGTTTCTCAACGGGAAGAG
Neph3 5'-118/Sp1 mutation -77 to -47 TTCTCAACGGGAAGAGAATGGAGCTCCCGGG
Primers for ChIP
Neph3-5' -81-FW ChIP -81 to -62 GAGTTTCTCAACGGGAAGAG
Neph3-5' +50-RV ChIP +50 to +32 GCCTCTGACGCTCTGAAAC
aPositions in genomic sequence [GenBank: AC002133] related to Neph3 transcription start site.
bFor oligonucleotides used in mutagenesis, only the sense primer is shown. The core element is underlined and the mutated oligonucleotides are 
shown in bold.Page 9 of 12
(page number not for citation purposes)
BMC Molecular Biology 2009, 10:83 http://www.biomedcentral.com/1471-2199/10/83moter plasmid and 50 ng of pPAC-Sp1 that expresses
human Sp1 driven by the Drosophila melanogaster actin
promoter (a gift from Prof. Dr. Guntram Suske, Philipps-
Universität Marburg). The corresponding empty vector
pPAC was used as a negative control. Luciferase activities
were measured 48 h after transfections and normalized by
the protein concentration measured using a Bradford pro-
tein assay (Bio-Rad).
Chromatin immunoprecipitation
The chromatin immunoprecipitation assay was per-
formed using the ChIP-IT™ Express (Active Motif,
Carlsbad, CA, USA) according to the manufacturer's
instructions with some modifications. Briefly, differenti-
ated human podocytes were cross-linked with 1% formal-
dehyde for 10 min at room temperature. Cells were
washed with ice-cold PBS and the fixation reaction was
stopped by adding 0.125 M glycine for 5 min at room
temperature. Cells were washed again with ice-cold PBS
and scraped from the dish. Cells were pelleted by centrif-
ugation and resuspended in the lysis buffer. After centrif-
ugation, pelleted nuclei were resuspended in the shearing
buffer, incubated on ice for 30 min and the chromatin was
sheared by sonication (Hielscher Ultrasonics GmbH, Tel-
tow, Germany) at 25% power 5 pulses of 20 sec each on
ice into fragments of approximately 200–600 bp. The
sheared chromatin was then centrifuged and the superna-
tant was collected. For immunoprecipitations, 60 μl of
chromatin was incubated with 1 μg of Sp1 (Santa Cruz
Biotechnology, Santa Cruz, CA, USA), NF-κB p65
(Abcam, Cambridge, UK) or NF-κB p50 (Abcam) anti-
bodies or with rabbit IgG (Zymed Laboratories, South San
Francisco, CA, USA), as a negative control, overnight at
4°C with gentle rotation. Immunocomplexes bound to
magnetic beads were collected using a magnetic stand,
washed extensively, and the protein/DNA crosslinks were
reversed and DNA eluted for real-time PCR analysis.
PCR mixtures contained 10 μl of the 2× Power SYBR®
Green PCR Master Mix (Applied Biosystems, Foster City,
CA, USA), 100 nM of each primer (Table 1) and 5 μl of
DNA in a total volume of 20 μl. The following PCR profile
in iCycler system (Bio-Rad) was used: preincubation at
95°C for 10 min, 40 cycles of 95°C for 30 s, 55°C for 30
s and 72°C for 30 s. The specificity of the PCR-products
was confirmed with melting curve analysis and by size as
determined by agarose gel electrophoresis.
RNA preparation, conventional and quantitative reverse 
transcription-PCR
Total RNA was isolated from human A293 embryonic kid-
ney cell line (non-transfected and transfected with NF-κB
p50 and p65 subunits) and differentiated human podo-
cytes with RNeasy Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer's instruction. RNA samples
were then treated with DNase I (Promega). 1 ug of each
DNase treated RNA sample was reverse transcribed into
cDNA using Primer random p(dN)6 (Roche) and M-MLV
Reverse Transcriptase (reverse transcriptase positive (RT+)
sample; Promega) as suggested in the manufacturer's
instructions. To confirm the RNA origin of the PCR sig-
nals, samples that were not reverse transcribed (RT- sam-
ples) were analyzed in parallel with the RT+ samples.
To detect endogenous Neph3 mRNA in A293 cells and
differentiated human podocytes, the conventional PCR
reaction was performed with HotStar Taq DNA polymer-
ase (Qiagen) in a total volume of 20 μl with 400 nM of
each primer (Table 1) and 1 μl of cDNA. The PCR was per-
formed as follows: preincubation at 95°C for 15 min, 40
cycles of 95°C for 30 s, 54°C for 30 s and 72°C for 30 s,
and final extension at 72°C for 5 min. PCR products were
visualized on a 1.5% agarose gel and the identity of the
amplification products of the RT+ samples was confirmed
by sequencing.
To determine the effect of NF-κB on Neph3 gene expres-
sion, the quantitative reverse transcription-PCR analysis
was performed in iCycler system (Bio-Rad) using TaqMan
chemistry. Commercially available pre-developed Taq-
Man gene expression assays (Applied Biosystems) for
human Neph3 (Assay ID: Hs00375638_m1) and human
GAPDH (Hs99999905_m1) were used in the the PCR
reaction in a total volume of 20 μl together with TaqMan
Fast Universal PCR Master Mix (Applied Biosystems) and
1 μl of cDNA. The following PCR profile was used: prein-
cubation at 95°C for 20 s, 40 cycles of 95°C for 3 s and
60°C for 30 s. Measurements were performed in triplicate.
The expression levels of Neph3 RNA were normalized to
GAPDH using the comparative Ct method (ΔΔCt).
Bioinformatics and statistics
MatInspector software using Genomatix matrixes http://
www.genomatix.de was exploited to study the putative
transcription factor binding sites in the Neph3 5' pro-
moter. The core similarity of 1.0 and matrix similarity of
0.8 were selected to scan sequences for matches.
Statistical analyses were performed using independent
samples t-test. P values of 0.05 or less were considered to
be statistically significant.
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